Cognitive decline and dementia affect approximately 30% to 40% of patients with idiopathic Parkinson's disease during the course of their illness. PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly. The nosological
Pael-R is accumulated in Lewy bodies of Parkinson's disease
β Scribed by Tetsuro Murakami; Mikio Shoji; Yuzuru Imai; Haruhisa Inoue; Takeshi Kawarabayashi; Etsuro Matsubara; Yasuo Harigaya; Atsushi Sasaki; Ryosuke Takahashi; Koji Abe
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 782 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b
## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio
## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PDβd). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PDβd (n = 15) and AD (n = 16
Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d